Patent details
EP2558123 Title: USES AND COMPOSITIONS FOR INHIBITION OF TREG CELLS, COMPRISING T HELPER CELLS AND CHAPERONINE-RICH CELL LYSATE
Basic Information
- Publication number:
- EP2558123
- PCT Application Number:
- US2011032090
- Type:
- European Patent Granted for LU
- Legal Status:
- Unitary Effect Registered
- Application number:
- EP117694257
- PCT Publication Number:
- WO2011130249
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- USES AND COMPOSITIONS FOR INHIBITION OF TREG CELLS, COMPRISING T HELPER CELLS AND CHAPERONINE-RICH CELL LYSATE
- French Title of Invention:
- UTILISATIONS ET COMPOSITIONS POUR INHIBER LES LYMPHOCYTES TREG, COMPRENANT DES CELLULES T HELPER ET UN LYSTA CELLULAIRE RICHE EN CHAPERONINES
- German Title of Invention:
- VERWENDUNGEN UND ZUSAMMENSETZUNG ZUR HEMMUNG VON TREG-ZELLEN, ENTHALTEND T-HELPER ZELLEN UND EIN ZELLLYSAT ANGEREICHERT FÜR CHAPERONINEN
- SPC Number:
Unitary Effect
- Unitary Effect Requested:
- Yes
- Unitary Effect Request Filing Date:
- 25/08/2023
- Link to UPP Register:
- European Patent Register
- Unitary Effect Request Withdrawal Date:
- Unitary Effect Status:
- Unitary Effect Registered
- Unitary Effect Acceptance Decision Date:
- 31/08/2023
- Unitary Effect Rejection Decision Date:
- Unitary Effect Date:
- 09/08/2023
- Unitary Effect Registration Date:
- 31/08/2023
- Unitary Effect Re-establishment of rights Filing Date:
- Unitary Effect Re-establishment of rights EPO Decision :
- Unitary Effect Re-establishment of rights EPO Decision Date:
- Explanatory Text UE:
- Safety Net Request Date:
- Safety Net Decision Date:
- Safety Net Decision Outcome:
- SPC Number:
Dates
- Filing date:
- 12/04/2011
- Grant date:
- 09/08/2023
- EP Publication Date:
- 20/02/2013
- PCT Publication Date:
- 20/10/2011
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 09/08/2023
- EP B1 Publication Date:
- 09/08/2023
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 12/04/2031
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 02/08/2023
- Name:
- Immunovative Therapies, Ltd.
- Address:
- POB 974, 60850 Shoham, Israel (IL)
Inventor
- Name:
- HAR-NOY, Michael
- Address:
- Israel (IL)
Priority
- Priority Number:
- 323557 P
- Priority Date:
- 13/04/2010
- Priority Country:
- United States (US)
Classification
- IPC classification:
- A61K 39/39; A61K 35/12; A61P 31/00; A61P 31/04; A61P 37/02; A61P 37/04; A61P 43/00; A61K 38/17; A61K 38/21; A61K 39/00; A61K 35/17; C12N 5/0783; A61P 35/00;
Publication
European Patent Bulletin
1
- Issue number:
- 202332
- Publication date:
- 09/08/2023
- Description:
- Grant (B1)
2
- Issue number:
- 202340
- Publication date:
- 04/10/2023
- Description:
- Unitary Effect Request Receipt
3
- Issue number:
- 202340
- Publication date:
- 04/10/2023
- Description:
- Unitary Effect Request Acceptance
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|